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Abstract In obesity, increased activity of the local renin–
angiotensin system (RAS) and enlarged adipocytes with
altered adipokine production are linked to the development
of obesity-related health problems and cardiovascular dis-
ease. Mixtures of conjugated linoleic acid (CLA) isomers
have been shown to reduce adipocyte size and alter the
production of adipokines. The objective of this study was
to investigate the effects of feeding individual CLA iso-
mers on adipocyte size and adipokines associated with the
local adipose RAS. Male fa/fa Zucker rats received either
(a) control, (b) cis(c)9,trans(t)11-CLA, or (c) t10,c12-CLA
diet for 8 weeks. The t10,c12-CLA isomer reduced adi-
pocyte size and increased cell number in epididymal adi-
pose tissue. RT-PCR and Western blot analysis revealed
that neither CLA isomer altered mRNA or protein levels of
angiotensinogen or AngII receptors in adipose tissue.
Likewise, levels of the pro-inﬂammatory cytokines TNF-a
and IL-6 or the anti-inﬂammatory cytokine IL-10 were
unchanged in adipose tissue. Similarly, neither CLA iso-
mer had any effect on phosphorylation nor DNA binding of
NF-jB. Our results suggest that although the t10,c12-CLA
isomer had beneﬁcial effects on reducing adipocyte size in
obese rats, this did not translate into changes in the local
adipose RAS or associated adipokines.
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Abbreviations
AngII Angiotensin II
ANOVA Analysis of variance
c cis
CLA Conjugated linoleic acid
IjBa Inhibitor protein kappa-B alpha
MAPK Mitogen-activated protein kinase
NF-jB Nuclear factor kappa-B
RAS Renin–angiotensin system
rp Ribosomal protein
t trans
TNF Tumor necrosis factor
Introduction
It is well known now that adipose tissue not only stores
triglycerides for energy but also functions as an endocrine
organ participating in energy homeostasis, neuroendocrine
control and immune functions [1, 2]. Increases in adipose
tissue, such as those observed in obesity, are associated
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accumulation and subsequent changes in the production of
bioactive proteins or adipokines to favor a more pro-
inﬂammatory proﬁle [3–5]. These changes are associated
with obesity-related health problems, the development of
metabolic syndrome and an increased risk of cardiovas-
cular disease [6–8]. Some of the pro-inﬂammatory adipo-
kines involved in pathogenesis of these diseases include
angiotensinogen, tumor necrosis factor (TNF)-a and inter-
leukin (IL)-6.
All components of the renin–angiotensin system (RAS),
including angiotensin II (AngII) and its precursor angioten-
sinogen, are present in adipose tissue and this local RAS has
beenimplicatedintheregulationofadiposegrowthaswellas
the regulation of blood pressure [9, 10]. In support of this
argument, mice that selectively over-express angiotensino-
gen in adipose tissue exhibit an increase in circulating
angiotensinogen and are hypertensive [9]. Upon binding to
its receptor, AngII also stimulates pro-inﬂammatory cyto-
kines through the activation of nuclear factor-jB (NF-jB)
[11], which further contributes to the pathogenesis of car-
diovascular complications [12].
Due to the large increases in obesity-related cardiovas-
cular complications, the need for preventative strategies is
at an all time high. The use of dietary compounds to pre-
vent or treat obesity-related cardiovascular risk factors may
be an attractive idea for some. Conjugated linoleic acid
(CLA) is a fatty acid derived from ruminant animals that is
being examined for its potential health beneﬁts [13]. Our
laboratory has shown that feeding a mixture of CLA iso-
mers to obese fa/fa Zucker rats favorably alters levels of
adipokines in serum and epididymal adipose tissue, and at
the same time reduces adipocyte size [14]. A recent study
by Martins et al. [15] also showed increased serum
adiponectin levels in obese Zucker rats given a mixture of
CLA isomers and the potential for other cardiovascular
beneﬁts such as lowered plasminogen activated inhibitor-1
levels. At this time, however, it remains unclear which
CLA isomer is responsible for reducing adipocyte size in
an obese model and if other adipose-derived proteins may
be affected. Research from other groups suggest that the
t10,c12-CLA isomer may be responsible for the cardio-
vascular beneﬁts, such as improving blood pressure by
reducing adipose angiotensinogen mRNA [16]. At this
point, however, it remains unclear whether these changes
in angiotensinogen mRNA will affect angiotensinogen
protein levels or if CLA would have an effect on AngII
receptors. Additionally, previous studies examining CLA
and NF-jB have primarily been carried out in culture
models [17, 18], leaving the effects of CLA isomers in vivo
on NF-jB activation in tissues still to be determined. This
study was therefore designed to investigate the effects of
individual CLA isomers on epididymal adipocyte size and
to examine the relationship with the local adipose RAS in
obesity. The study focused on epididymal adipose tissue as
a visceral adipose depot because visceral adiposity is
associated with metabolic complications of obesity and
cardiovascular disease and is strong predictor of obesity-
related risk factors and mortality [19, 20].
Materials and Methods
Animals and Diet
During an 8-week experimental period, 6-week old male
fa/fa Zucker rats (n = 6/group; Harlan, Indianapolis, IN,
USA) received diets based on the AIN-93 formula differing
intheamountsofCLAisomersaspreviouslypublished[21].
There were three groups (a) control diet (b) 0.4% (w/w)
cis(c)9,trans(t)11-CLA diet, and (c) 0.4% (w/w) t10,c12-
CLA diet. At the end of the feeding period, rats were
euthanized by CO2 asphyxiation and epididymal adipose
tissue was dissected, frozen in liquid nitrogen or Cryogel
embeddingmediumandsubsequentlystoredat-80 Cuntil
analyzed.TheUniversityofManitobaProtocolManagement
and Review Committee approved the animal protocol which
wasinagreementwiththeCanadianCouncilonAnimalCare
Guidelines [22].
Morphometry
Tissues sections (10 lm thick) were cut on a cryotome and
mounted on SuperFrost Plus glass slides. Sections were
ﬁxed in formaldehyde and assessed under a light micro-
scope (BH2-RFCA; Olympus) equipped with a camera (Q-
Imaging). Using Image J software as previously described
[14], a continuous block of 25 cells was measured in every
ﬁeld to determine average cell size (lm
2) and mean adi-
pocyte size per group was calculated. Based on Sturges’
rule [23], 10 different classes of adipocyte area were
determined and the cell size distribution for each treatment
group was expressed as a percentage. The number of adi-
pocyte was assessed by counting a 160 lm
2 area in the
centre of each ﬁeld/section and the mean number per group
was calculated.
RT-PCR Analysis
Total RNA was isolated from epididymal adipose tissue
using TRIzol reagent. The concentration of RNA and the
purity of the samples were assessed spectrophotometrically.
RNA was digested with DNase, reverse transcribed into
cDNA and ampliﬁed with an Access RT-PCR system kit
(Promega). Primer sequences for detection of angiotensin-
ogen, AngII receptor1a, AngII receptor1b, TNF-a, IL-6,
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123IL-10 and ribosomal protein L32 (rpL32) mRNA can be
found in Table 1. In view of the fact that high levels of pro-
inﬂammatory mediators have been linked to obesity and
CLA is considered effective against obesity [24], we also
examined the anti-inﬂammatory mediator IL-10. cDNA
products were run on an agarose gel, visualized with Vista
Green Nucleic Acid Stain and relative intensity of the bands
was quantiﬁed by densitometry. Results are expressed as
arbitrary units after normalization to rpL32 expression.
Protein Extraction and Western Blotting
The bicinchoninic acid assay (Pierce) was used to deter-
mine total protein in samples isolated from adipose tissue
using a mortar and pestle and 39 sodium dodecyl sulfate
sample buffer. Adipose samples (15 lg protein) were
analyzed by Western blotting as described previously [25]
with antibodies (diluted 1:1,000) for angiotensinogen
(Fitzgerald), AngII receptor 2 (Santa Cruz), TNF-a (Cell
Signaling), IL-6 (Biosource), IL-10 (Biosource), NF-jB
(Cell Signaling), F4/80 (Abcam) and total mitogen-acti-
vated protein kinase (MAPK) (Cell Signaling). The latter
was used to account for possible variability in sample
loading. Autoradiography and scanning densitometry with
Quantity One image analysis software (BioRad) were used
to capture and quantify band intensities.
NF-jB Activation
Nuclear extracts from epididymal adipose tissue samples
were prepared using a Nuclear Extract Kit according to
manufacturer’s instructions (Active Motif). NF-jB binding
activity was determined using a TransAM NF-jB Tran-
scription Factor ELISA Kit according to manufacturer’s
instructions (Active Motif).
Statistical Analysis
Data were analyzed with Statistical Analysis Software
(SAS 6.04; SAS Institute, Cary, NC, USA) to examine the
effect of diet on cell size, mRNA and protein levels by a
one-way analysis of variance (ANOVA) followed by
Duncan’s multiple range test. Differences were considered
signiﬁcant at P\0.05 and all results are expressed as
means ± standard error (SEM).
Results
Growth Performance and Feed Intake
There were no signiﬁcant differences in body weight
gained (control 433 ± 10 g; c9,t11-CLA 452 ± 9g ;
t10,c12-CLA 453 ± 8 g) or epididymal adipose mass (data
not shown) among groups. Likewise, daily food intake was
similar among groups (control 27.2 ± 0.5 g/day; c9,t11-
CLA 28.8 ± 0.6 g/day; t10,c12-CLA 28.9 ± 0.4 g/day).
Adipocyte Size
Previously we reported that a mixture of CLA isomers
reduced adipocyte size [14], however, the contribution of
the individual CLA isomers was not investigated. There-
fore, the current study was designed to examine the effect
of individual CLA isomers on adipocyte size. The group
receiving the t10,c12-CLA isomer had 60% smaller adi-
pocytes compared to the control and c9,t11-CLA groups
(Fig. 1a, b). The distribution pattern of cell size shows that
80% of adipocytes in the t10,c12-CLA isomer group were
\2,000 lm
2, with less than 2% of cells [5,000 lm
2,
whereas the control group and the c9,t11-CLA group had a
Table 1 Primer sequences for
RT-PCR
F Forward primer, R reverse
primer
Gene name Primer sequence
Angiotensinogen F: 50-CAC GGA CAG CAC CCT ATT TT-30
R: 50-GCT GTT GTC CAC CCA GAA CT-30
TNF-a F: 50-GTC AGC CGA TTT TGC CAT TTC-30
R: 50-AAC GAT GAA CAC GCC AGT-30
IL-6 F: 50-CCC AAC TTC CAA TGC TCT CCT AAT G-30
R: 50-GCA CAC TAG GTT TGC CGA GTA GAC C-30
IL-10 F: 50-GGC TCA GCA CTG CTA TGT TGC C-30
R: 50-AGC ATG TGG GTC TGG CTG ACT G-30
rpL32 F: 50-TAA GCG AAA CTG GCG GAA AC-30
R: 50-GCT CGT CTT TCT ACG ATG GCT T-30
AngII receptor type 1a F: 50-CTC AAG CCT GTC TAC GAA AAT GAG-30
R: 50-TAG ATC CTG AGG CAG GGT GGA T-30
AngII receptor type 1b F: 50-CTT TCC TAC CGC CCT TCA GAT A-30
R: 50-TGA GTG CTT TCT CTG CTT CAA C-30
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12353–63% of cells in the 2,000–5,000 lm
2 range and more
than 25% of the cells were in excess of 5,000 lm
2
(Fig. 3c). The group receiving the t10,c12-CLA isomer
also had 43% more adipocytes compared to the control and
c9,t11-CLA groups (Fig. 1d).
Adipokines in Adipose Tissue
It is suggested that adipocyte size alters the production of
adipokines [3–5] and because the t10,c12-CLA isomer
reduced adipocyte size we decided to explore the adipokine
status in the adipose tissue. Unexpectedly, the AngII pre-
cursor angiotensinogen was not changed at the gene
(Fig. 2a) or protein level (Fig. 3a) in the adipose tissue of
the rats fed CLA isomers. There was also no change in
AngII receptors (Figs. 2e, f, 3b). Similarly, TNF-a, IL-6
and IL-10 mRNA were unchanged with CLA isomers
(Fig. 2b–d). Likewise, protein levels of TNF-a, IL-6 and
IL-10 were similar among all groups (Fig. 3c–e). Because
macrophage inﬁltration occurs in obesity and contributes to
the pro-inﬂammatory state of adipose tissue [5], the mac-
rophage marker F4/80 was examined. None of the diets
inﬂuenced the levels of macrophages within the adipose
tissue (Fig. 4a).
NF-jB Activation
Given that NF-jB regulates many genes involved in
inﬂammation [11], we next examined the levels of phos-
phorylated NF-jB and its promoter binding activity in
epididymal adipose tissue. Neither CLA isomer affected
either NF-jB phosphorylation (Fig. 4b) or DNA binding
(Fig. 4c).
Discussion
The current study has demonstrated that feeding t10,c12-
CLA to obese fa/fa Zucker rats reduces epididymal adi-
pocyte size and increases cell number. The effect of CLA
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Fig. 1 Morphometry of
epididymal adipose tissue from
fa/fa Zucker rats fed CLA
isomers for 8 weeks (n =
5/group). Adipocyte size
(a) was quantiﬁed for each
treatment group and cell size
(b) is reported in lm
2 for the
overall mean ± SEM. The
distribution of adipocyte size
(c) in each treatment group is
also shown. Number of
adipocytes (d) for each
treatment group is reported as
overall mean number of
cells ± SEM per 160 mm
2.
Means with different letters are
signiﬁcantly different
(P B 0.05) as determined by
Duncan’s multiple range test.
Control, fa/fa Zucker rats fed
0% CLA; CLA-9,11, fa/fa
Zucker rats fed 0.4%
c9,t11-CLA; CLA-10,12, fa/fa
Zucker rats fed 0.4%
t10,c12-CLA
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123on adipocyte size in rats has previously been examined
with either a mixture of CLA isomers [14, 26] or single
isomers in a non-obese model [27]. Earlier work examining
the effects of CLA mixtures on adipocyte size revealed that
other types of fat in the diet may inﬂuence the effects of
CLA [14, 26, 27]. For example, rats consuming diets based
on a soybean oil background and supplemented with a
mixture of CLA isomers have reduced cell size [14, 26],
whereas the effects of CLA are lost when the background
consists of saturated palm oil [27]. In the same study that
used palm oil, isomer speciﬁc effects were also examined
and the c9,t11-CLA isomer increased adipocyte size and
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Fig. 2 Epididymal adipose
tissue mRNA levels of
angiotensinogen (a), TNF-a (b),
IL-6 (c), IL-10 (d), AT1a
(e) and AT1b (f)i nfa/fa Zucker
rats (n = 6/group). mRNA was
analyzed using RT-PCR. The
relative intensity of the bands
was quantiﬁed by densitometry
and normalized to that of
ribosomal protein L32.
Representative gels are shown
for each plot. Data are presented
as means ± SEM. No
signiﬁcant differences
(P[0.05) were detected by
ANOVA. Control, fa/fa Zucker
rats fed 0% CLA; CLA-9,11, fa/
fa Zucker rats fed 0.4%
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t10,c12-CLA; AT1a, AngII
receptor type 1a; AT1b, AngII
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123consequently decreased the number of adipocytes per unit
of area in the inguinal and retroperitoneal depots of Wistar
rats [27]. The increase observed with the c9,t11-CLA iso-
mer was abolished when a mixture of CLA isomers was
provided [27], suggesting t10,c12-CLA may have beneﬁ-
cial effects for reducing cell size. Lopes et al [27] also
showed rats receiving the t10c12-CLA isomer had signif-
icantly more adipocytes per unit area compared to the
group receiving the c9,t11-CLA isomer. In agreement
with this hypothesis, our study demonstrated that the
t10,c12-CLA isomer is responsible for reducing cell size
and increasing adipocyte number. Additionally, because
earlier work in fa/fa Zucker rats fed a mixture of CLA
isomers demonstrated that reduced adipocyte size was
associated with altered adipokines, we wanted to test if the
beneﬁcial changes in adipocytes size observed with the
t10,c12-CLA isomer also produce changes in local adipose
RAS and cellular adipokine status.
Evidence suggests that obesity-related complications
may be due in part to the activation of a local RAS in
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Fig. 3 Epididymal adipose
tissue protein levels of
angiotensinogen (a), AngII
receptor type 2 (b), TNF-a (c),
IL-6 (d) and IL-10 (e)i nfa/fa
Zucker rats (n = 4–6/group).
Protein levels were measured
using Western blot analysis. The
relative intensity of the protein
bands was quantiﬁed by
densitometry and normalized to
that of MAPK. Representative
Western blots are shown for
each plot. Data are presented as
means ± SEM. No signiﬁcant
differences (P[0.05) were
detected by ANOVA. Control,
fa/fa Zucker rats fed 0% CLA;
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123adipose tissue [9, 28, 29], however, in the current study, no
signiﬁcant differences were detected in adipose angioten-
sinogen levels or AngII receptors of CLA fed rats. To our
knowledge this is the ﬁrst report describing the effect of
CLA isomers on AngII receptors. In contrast, previous
work showed OLETF rats fed the t10,c12-CLA isomer had
suppressed angiotensinogen gene expression in peri-renal
adipose tissue [16]. Furthermore, Hainault et al. [30]
showed angiotensinogen levels were greater in inguinal
adipocytes isolated from obese compared to lean Zucker
rats. Perhaps assessment of angiotensinogen mRNA or
protein levels in different adipose depots or different
models may be responsible for the varying results. Epi-
didymal adipose tissue was investigated in this study
because alterations in adipokine levels in epididymal adi-
pose tissue have been noted in this animal model [14]. We
measured angiotensinogen protein levels in epididymal
adipose tissue as well as peri-renal adipose tissue (data not
shown), however, we were unable to detect any dietary
effects on angiotensinogen levels in either depot. Addi-
tionally, it may be that a reduction in fat mass is required in
rats to achieve changes in angiotensinogen mRNA [31, 32].
Despite observing changes in adipocyte size, we did not
note any changes in adipokine status or macrophage
inﬂammation in the epididymal adipose tissue. However, it
is still possible that the inﬂammatory mediators produced
in liver, spleen, or other tissues could affect changes
observed with CLA supplementation. Gollisch et al. [33]
examined exercise as a means to reduce cell size and
inﬂammatory cytokines in Sprague Dawley rats, however,
results showed that maintenance of a small adipocyte size
by exercise did not alter IL-6 or TNF-a mRNA compared
to sedentary rats with increased adipocyte size. Thus,
lifestyle interventions aimed at altering adipocyte size to
improve inﬂammatory adipokine status of rats require more
investigation before conclusions can be drawn. In contrast,
studies in mice and isolated human adipocytes have clearly
demonstrated that the t10,c12-CLA isomer increases
mRNA levels of IL-6 and TNF-a in adipose tissue [17, 34].
Unlike the rat model used in the current study, mice
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kits (Active Motif). Data are presented as means ± SEM. No
signiﬁcant differences (P[0.05) were detected by ANOVA. Control,
fa/fa Zucker rats fed 0% CLA; CLA-9,11, fa/fa Zucker rats fed 0.4%
c9,t11-CLA; CLA-10,12, fa/fa Zucker rats fed 0.4% t10,c12-CLA;
nuclear extract, positive control
b
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123(irrespective of their metabolic state) also display increased
macrophage inﬁltration when given t10,c12-CLA or a
mixture of CLA isomers [17, 35–37]. This study thus adds
to the literature that has demonstrated differences in the
inﬂammatory response between mice and rats when given
the t10,c12-CLA isomer.
Previous work using cell culture models suggests that
CLA isomers may be able to modulate NF-jB activity [18,
38, 39], thus to our knowledge this is the ﬁrst study to
examine phosphorylation and binding activity of NF-jBi n
adipose tissue after dietary intervention. Our results in
obese rats show no effect of either CLA isomer on NF-jB
phosphorylation or binding activity, however, these results
were not unexpected given that levels of the inﬂammatory
adipokines examined were unchanged by the treatments. In
contrast to the current study, isolated human adipocytes
treated directly with t10,c12-CLA isomer have increased
TNF-a and IL-6 mRNA and this was associated with an
increase in IjBa phosphorylation and NF-jB binding
activity [18]. Likewise, increased NF-jB binding activity
was demonstrated in human umbilical vein endothelial
cells treated with either the c9,t11-CLA or t10,c12-CLA
isomer [38]. In a mouse macrophage cell line (RAW264.7),
however, a mixture of CLA isomers reduced phosphory-
lated IjBa and NF-jB binding activity [39]. Additionally,
a signiﬁcant increase in NF-jB activity is observed in
murine myotubes treated with t10,c12-CLA isomer but not
murine myoblasts [40]. Thus, it appears that differing
results occur not only between obese rat and mouse models
but also different cell types, emphasizing the need for more
research in this area. Future work is necessary to determine
cell and species-speciﬁc effects of CLA isomers, as well as
determine if therapeutic strategies that reduce adipocyte
size can directly alter adipokine production and secretion.
In conclusion, this study demonstrates that t10,c12-CLA
is the isomer responsible for the reduction in adipocyte size
that was observed in an earlier study using a mixture of
CLA isomers in fa/fa Zucker rats [14]. The reduction in
adipocyte size, however, did not alter components the local
adipose RAS such as angiotensinogen and AngII receptors,
or associated adipokines such as TNF-a, IL-6 and IL-10.
Furthermore, CLA isomers have no inﬂuence on macro-
phage inﬁltration or NF-jB activity in the adipose tissue of
obese Zucker rats. Therefore, further work is needed to
determine if there are any functional changes in the adi-
pocyte as a result of reduced cell size via t10,c12-CLA
isomer treatment.
Acknowledgments We would like to thank Danielle Stringer and
Lisa Rigaux for help with the animal care and the contribution of the
St. Boniface Hospital and Research Foundation towards infrastructure
support. Financial support for this study was provided by grants from
Dairy Farmers of Canada (C.T. and P.Z.) and Canada-Manitoba Agri-
Food Research and Development Initiative (C.T. and P.Z.), and a
Natural Sciences and Engineering Research Council of Canada as
postgraduate scholarship (V.D.).
Conﬂict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Ahima RS (2006) Adipose tissue as an endocrine organ. Obesity
(Silver Spring) 14(Suppl 5):242S–249S
2. Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P,
Mikhailidis DP (2010) Should adipokines be considered in the
choice of the treatment of obesity-related health problems? Curr
Drug Targets 11:122–135
3. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE,
Cushman SW, Periwal V (2009) Hypertrophy and/or hyperplasia:
dynamics of adipose tissue growth. PLoS Comput Biol
5:e1000324
4. Skurk T, Alberti-Huber C, Herder C, Hauner H (2007) Rela-
tionship between adipocyte size and adipokine expression and
secretion. J Clin Endocrinol Metab 92:1023–1033
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL,
Ferrante AW Jr (2003) Obesity is associated with macrophage
accumulation in adipose tissue. J Clin Invest 112:1796–1808
6. Inadera H (2008) The usefulness of circulating adipokine levels
for the assessment of obesity-related health problems. Int J Med
Sci 5:248–262
7. Berg AH, Scherer PE (2005) Adipose tissue, inﬂammation, and
cardiovascular disease. Circ Res 96:939–949
8. Matsuzawa Y (2005) White adipose tissue and cardiovascular
disease. Best Pract Res Clin Endocrinol Metab 19:637–647
9. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A,
Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux
J, Meneton P, Teboul M (2001) Adipose angiotensinogen is
involved in adipose tissue growth and blood pressure regulation.
FASEB J 15:2727–2729
10. KouyamaR,SuganamiT,NishidaJ,TanakaM,ToyodaT,KisoM,
Chiwata T, Miyamoto Y, Yoshimasa Y, Fukamizu A, Horiuchi M,
Hirata Y, Ogawa Y (2005) Attenuation of diet-induced weight
gain and adiposity through increased energy expenditure in mice
lacking angiotensin II type 1a receptor. Endocrinology 146:3481–
3489
11. Sanz-Rosa D, Oubina MP, Cediel E, de Las Heras N, Vegazo O,
Jimenez J, Lahera V, Cachofeiro V (2005) Effect of AT1 receptor
antagonism on vascular and circulating inﬂammatory mediators
in SHR: role of NF-kappaB/IkappaB system. Am J Physiol Heart
Circ Physiol 288:H111–H115
12. Rodriguez-Iturbe B, Sindhu RK, Quiroz Y, Vaziri ND (2005)
Chronicexposuretolowdosesofleadresultsinrenalinﬁltrationof
immune cells, NF-kappaB activation, and overexpression of tub-
ulointerstitial angiotensin II. Antioxid Redox Signal 7:1269–1274
13. Benjamin S, Spener F (2009) Conjugated linoleic acids as func-
tional food: an insight into their health beneﬁts. Nutr Metab
(Lond) 6:36
14. Noto A, Zahradka P, Yurkova N, Xie X, Truong H, Nitschmann
E, Ogborn MR, Taylor CG (2007) Dietary conjugated linoleic
acid decreases adipocyte size and favorably modiﬁes adipokine
status and insulin sensitivity in obese, insulin-resistant rats.
Metabolism 56:1601–1611
1032 Lipids (2010) 45:1025–1033
12315. Martins SV, Lopes PA, Alfaia CM, Rodrigues PO, Alves SP,
Pinto RM, Castro MF, Bessa RJ, Prates JA (2010) Serum
adipokine proﬁle and fatty acid composition of adipose tissues are
affected by conjugated linoleic acid and saturated fat diets in
obese Zucker rats. Br J Nutr 103:869–878
16. Nagao K, Inoue N, Wang YM, Hirata J, Shimada Y, Nagao T,
Matsui T, Yanagita T (2003) The 10trans,1 2 cis isomer of con-
jugated linoleic acid suppresses the development of hypertension
in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys
Res Commun 306:134–138
17. Poirier H, Shapiro JS, Kim RJ, Lazar MA (2006) Nutritional
supplementation with trans-10, cis-12-conjugated linoleic acid
induces inﬂammation of white adipose tissue. Diabetes
55:1634–1641
18. Chung S, Brown JM, Provo JN, Hopkins R, McIntosh MK (2005)
Conjugated linoleic acid promotes human adipocyte insulin
resistance through NFkappaB-dependent cytokine production.
J Biol Chem 280:38445–38456
19. Cameron AJ, Dunstan DW, Owen N, Zimmet PZ, Barr EL,
Tonkin AM, Magliano DJ, Murray SG, Welborn TA, Shaw JE
(2009) Health and mortality consequences of abdominal obesity:
evidence from the AusDiab study. Med J Aust 191:202–208
20. Despres JP, Arsenault BJ, Cote M, Cartier A, Lemieu I (2008)
Abdominal obesity: the cholesterol of the 21st century? Can J
Cardiol 24(Suppl D):7D–12D
21. Ruth MR, Taylor CG, Zahradka P, Field CJ (2008) Abnormal
immune responses in fa/fa Zucker rats and effects of feeding
conjugated linoleic acid. Obesity (Silver Spring) 16:1770–1779
22. Canadian Council on Animal Care (CCAC) (1993) Guide to the
care and use of experimental animals. http://www.ccac.ca/en/
CCAC_Programs/Guidelines_Policies/GUIDES/ENGLISH/toc_v1.
htm. Accessed 07/22 2009
23. Sturges HA (1926) The choice of a class interval. J Am Stat
Assoc 21:65–66
24. Benjamin S, Spener F (2009) Conjugated linoleic acids as func-
tional food: an insight into their health beneﬁts. Nutr Metab
(Lond) 6:36
25. Yau L, Elliot T, Lalonde C, Zahradka P (1998) Repression of
phosphoenolpyruvate carboxykinase gene activity by insulin is
blocked by 3-aminobenzamide but not by PD128763, a selective
inhibitor of poly(ADP-ribose) polymerase. Eur J Biochem
253:91–100
26. Azain MJ, Hausman DB, Sisk MB, Flatt WP, Jewell DE (2000)
Dietary conjugated linoleic acid reduces rat adipose tissue cell
size rather than cell number. J Nutr 130:1548–1554
27. Lopes PA, Martins SV, Pinho MS, Alfaia CM, Fontes CM, Ro-
drigues PO, Morais GS, Castro MF, Pinto R, Prates JA (2008)
Diet supplementation with the cis-9, trans-11 conjugated linoleic
acid isomer affects the size of adipocytes in Wistar rats. Nutr Res
28:480–486
28. Engeli S, Negrel R, Sharma AM (2000) Physiology and patho-
physiology of the adipose tissue renin–angiotensin system.
Hypertension 35:1270–1277
29. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall
DC, Cassis LA (2004) Activation of the systemic and adipose
renin–angiotensin system in rats with diet-induced obesity and
hypertension. Am J Physiol Regul Integr Comp Physiol 287:
R943–R949
30. Hainault I, Nebout G, Turban S, Ardouin B, Ferre P, Quignard-
Boulange A (2002) Adipose tissue-speciﬁc increase in angio-
tensinogen expression and secretion in the obese (fa/fa) Zucker
rat. Am J Physiol Endocrinol Metab 282:E59–E66
31. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M,
Luft FC, Sharma AM (2005) Weight loss and the renin–angio-
tensin–aldosterone system. Hypertension 45:356–362
32. Nagao K, Inoue N, Wang YM, Hirata J, Shimada Y, Nagao T,
Matsui T, Yanagita T (2003) The 10trans,1 2 cis isomer of con-
jugated linoleic acid suppresses the development of hypertension
in Otsuka Long-Evans Tokushima fatty rats. Biochem Biophys
Res Commun 306:134–138
33. Gollisch KS, Brandauer J, Jessen N, Toyoda T, Nayer A,
Hirshman MF, Goodyear LJ (2009) Effects of exercise training
on subcutaneous and visceral adipose tissue in normal- and high-
fat diet-fed rats. Am J Physiol Endocrinol Metab 297:E495–E504
34. Martinez K, Kennedy A, West T, Milatovic D, Aschner M,
McIntosh M (2010) trans-10, cis-12-Conjugated linoleic acid
instigates inﬂammation in human adipocytes compared with
preadipocytes. J Biol Chem 285:17701–17712
35. Wendel AA, Purushotham A, Liu LF, Belury MA (2008) Con-
jugated linoleic acid fails to worsen insulin resistance but induces
hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid
Res 49:98–106
36. LaRosa PC, Miner J, Xia Y, Zhou Y, Kachman S, Fromm ME
(2006) Trans-10, cis-12 conjugated linoleic acid causes inﬂam-
mation and delipidation of white adipose tissue in mice: a
microarray and histological analysis. Physiol Genomics 27:
282–294
37. Liu LF, Purushotham A, Wendel AA, Belury MA (2007) Com-
bined effects of rosiglitazone and conjugated linoleic acid on
adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed
mice. Am J Physiol Gastrointest Liver Physiol 292:G1671–
G1682
38. Nakamura YK, Omaye ST (2009) Conjugated linoleic acid iso-
mers’ roles in the regulation of PPAR-gamma and NF-kappaB
DNA binding and subsequent expression of antioxidant enzymes
in human umbilical vein endothelial cells. Nutrition 25:800–811
39. Cheng WL, Lii CK, Chen HW, Lin TH, Liu KL (2004) Contri-
bution of conjugated linoleic acid to the suppression of inﬂam-
matory responses through the regulation of the NF-kappaB
pathway. J Agric Food Chem 52:71–78
40. Hommelberg PP, Plat J, Remels AH, van Essen AL, Kelders MC,
Mensink RP, Schols AM, Langen RC (2010) Trans-10, cis-12
conjugated linoleic acid inhibits skeletal muscle differentiation
and GLUT4 expression independently from NF-kappaB activa-
tion. Mol Nutr Food Res
Lipids (2010) 45:1025–1033 1033
123